Neutropenia after ocrelizumab treatment in patients with multiple sclerosis: a single-centre case series and systematic review of literature

被引：0
|
作者：
Silva, Joana Almada [1 ]
Delgado, Sofia [1 ]
Santos, Mariana [1 ]
Leitao, Lia [1 ]
机构：
[1] Hosp Prof Doutor Fernando Fonseca, Dept Neurol, EPE, Amadora, Portugal
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P890/4082
引用
收藏
页码：1187 / 1187
页数：1
相关论文
共 50 条
  • [1] Ocrelizumab-induced neutropenia in people with multiple sclerosis: a single-centre study
    Sartori, Arianna
    Favero, Anna
    Rossi, Lucrezia
    Dinoto, Alessandro
    Miotto, Domitilla
    Baldini, Sara
    Bratina, Alessio
    Bosco, Antonio
    Manganotti, Paolo
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 631 - 631
  • [2] Breast Carcinoma After Ocrelizumab Therapy in Multiple Sclerosis Patients: A Case Series and Literature Review
    Andrews, Kelsey
    Kramer, Joshua
    Casinelli, Gabriella
    Ali, Farman
    Sriwastava, Shitiz
    ANNALS OF NEUROLOGY, 2021, 90 : S23 - S23
  • [3] Breast Carcinoma After Ocrelizumab Therapy in Multiple Sclerosis Patients: A Case Series and Literature Review
    Kelsey, Andrew
    Casinelli, Gabriella
    Tandon, Medha
    Sriwastava, Shitiz
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2021, 13
  • [4] Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature
    Zanetta, Chiara
    Robotti, Micaela
    Nozzolillo, Agostino
    Sangalli, Francesca
    Liberatore, Giuseppe
    Nobile-Orazio, Eduardo
    Filippi, Massimo
    Moiola, Lucia
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 409
  • [5] BILIARY CAST SYNDROME AFTER OLT: A SINGLE-CENTRE CASE SERIES AND LITERATURE REVIEW
    Cintolo, M.
    Tringali, A.
    Forti, E.
    De Carlis, L.
    Belli, L.
    De Gasperi, A.
    Dioscoridi, L.
    Cristoferi, L.
    Bonato, G.
    Mutignani, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E145 - E145
  • [6] The Role of Ocrelizumab in Multiple Sclerosis Treatment; Literature Review
    Alenazy, Rawan Hamdan
    Abualshamat, Mohammed Majed S.
    Alqahs, Fahad Sh S. Dh
    Almutairi, Abdullah F. N.
    Alharbi, Mohammed Khalid Moslih
    Alkhuraimi, Bandar Mohammad
    Dhamiri, Yahya Abdulrahman
    Alshahrani, Mohammed Munir Abdullah
    Alshahrani, Kholoud Mesfer
    Alghamdi, Mohammed Abdullah
    Alenezi, Reham Khaleef
    ARCHIVES OF PHARMACY PRACTICE, 2021, 12 (03) : 117 - 120
  • [7] Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature review
    Jovicevic, Vanja
    Bila, Jelena
    Mesaros, Sarlota
    Pekmezovic, Tatjana
    Drulovic, Jelena
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (5-6) : 354 - 356
  • [8] Ibrutinib therapy related uveitis: A single-centre case series and literature review
    Kalakonda, Anita J. M.
    Jeffers, Lisa
    Wells, Matthew
    Pettitt, Andrew
    Kalakonda, Nagesh
    Arumainathan, Arvind
    Smith, Jefferey
    Singh, Vikram
    Williams, Stella
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 194 - 194
  • [9] A case series of late onset neutropenia following ocrelizumab therapy in multiple sclerosis (MS)
    Talaei, M.
    Petheram, K.
    Ingram, G.
    Trip, A.
    Pearson, O.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 252 - 252
  • [10] Safety profile of Ocrelizumab for the treatment of multiple sclerosis: a systematic review
    Luzon, C.
    Ng, H. S.
    Tremlett, H.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 543 - 543
12345